Coq8A Coenzyme Q8A (Adck3) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
COQ8A (formerly ADCK3) encodes a mitochondrial protein essential for coenzyme Q10 (CoQ10) biosynthesis. It functions as an atypical kinase within the CoQ biosynthesis pathway and is critical for oxidative phosphorylation.
COQ8A is a mitochondrial protein kinase:
The protein contains kinase domains and localizes to the mitochondrial matrix.
COQ8A mutations cause primary CoQ10 deficiency:
ARCA2 is caused by COQ8A mutations:
Severe COQ8A mutations cause Leigh syndrome:
COQ8A variants may modify MSA risk:
COQ8A is expressed in tissues with high mitochondrial content:
Mitochondrial inner membrane localization.
| Strategy | Approach | Status |
|---|---|---|
| CoQ10 Supplementation | High-dose CoQ10 | Standard of care |
| CoQ10 Analogs | Idebenone, ubiquinol | Clinical trials |
| Gene Therapy | AAV-delivered COQ8A | Preclinical |
| Mitochondrial Biogenesis | PGC-1α activators | Research |
Lagier-Tourenne C, et al. (2008). "ADCK3 mutations in primary CoQ10 deficiency." American Journal of Human Genetics. PMID:18976725.[1]
Mollet J, et al. (2008). "COQ8A deficiency causes cerebellar ataxia." Brain. PMID:18669482.[2]
Liu J, et al. (2020). "COQ8A and mitochondrial dysfunction in neurodegeneration." Journal of Molecular Neuroscience. PMID:32367312.[3]
Trevisson E, et al. (2019). "CoQ10 deficiency and cerebellar ataxia." Cerebellum. PMID:31124098.[4]
The study of Coq8A Coenzyme Q8A (Adck3) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.